← Back to SONM

DNA X, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 19/08/2026Mar 2026Filed 20/05/2026Sep 2025Filed 31/10/2025Jun 2025Filed 19/08/2026Mar 2025Filed 20/05/2026Sep 2024Filed 31/10/2025Jun 2024Filed 08/08/2025Mar 2024Filed 12/05/2025
$16$11$17$15$12$9.1
−$1.2$6.3−$4.8−$7.5$0.5−$2.5−$6.6−$2.9
−$0.92$5.01−$4.83−$14.15$1.41−$9.32−$1.41−$0.65
1.41.310.34.74.4

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.